Stock Updates

Today’s Top Gainers in the Market Boston Scientific Corporation (NYSE:BSX) from Healthcare

Today’s top gainers include the company Boston Scientific Corporation (NYSE:BSX) which is in the industry Medical Appliances & Equipment, gaining -0.29% today. In the last week its performance is 1.21%, and 6.64% for the past quarter. Currently, Boston Scientific Corporation, BSX has a target price of 27.26, so today’s gain of -0.29% is a significant step towards its target price. The GAP today is therefore 0.29%.

Boston Scientific Corporation (NYSE:BSX), has a market cap of 33106.89, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 94.20%.

At the current price of 24.26, it has a dividend yield of *TBA, and its target price is 27.26. This is with a profit margin of -4.30%, and total debt/equity of 0.87. Boston Scientific Corporation (NYSE:BSX) has a P/E of *TBA, as well as a forward P/E of 19.28.

With a current EPS of -0.26, and a forecasted EPS growth for next year at 14.26%,Boston Scientific Corporation (NYSE:BSX) has had a EPS growth for the past five years at 24.00%. For the next five years EPS growth is projected to be 13.07%.

Performance for the year is 46.76%. Since its IPO date on 5/19/1992, the total performance to date is 31.56%.

Volume today for Boston Scientific Corporation (NYSE:BSX), is 5493000, while its average volume is 9639.12. Whilst the total gain today was -0.29%, it did have a day high of -2.14%.

Volatility for this week has been at 1.57%, and 1.31% for the month. The 52-week low for Boston Scientific Corporation, BSX has been 54.82%, while the 52-week-high has reached -2.14%.

Looking at its return of investments, which is 0.70%, and its return on assets is -1.90%. Boston Scientific Corporation (NYSE:BSX) has an operating margin of -7.70%. With a sales growth of 15.40% quarter over quarter. Bearing in mind that Boston Scientific Corporation, BSX is in the sector Healthcare, its long-term debt/equity is 0.83, and has a current ratio of 1 and 0.7 for quick ratio.

So what is the value of Boston Scientific Corporation? Well its PEG is *TBA, and the P/S is 4.16, along with a P/B of 5.3. Meanwhile it has a p/cash of 75.59.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment